Signal2026-04-16
ClinicalTrials.gov

[PHASE2] EncompaSSc: Evaluation of MTX-474 in Participants With Diffuse Cutaneous Systemic Sclerosis (dcSSc)

Part of

Phase 2 Clinical Trial Developments

Open primary sourceSee the whole picture